Hem › Bukspottkörtelcancer › Alabama
Kliniska studier för Bukspottkörtelcancer i Alabama
11 studier för Bukspottkörtelcancer söker deltagare vid platser i Alabama.
Städer i Alabama
Officiell studietext (engelska)
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Clearview Cancer Institute, Huntsville
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 5 okt. 2026 · NCT07562152A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital, Birmingham
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT06760819DESTINY-PANTUMOUR04
- Research Site, Birmingham
RekryterarObservationsstudie
Ålder 18 till 130 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07124000A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- The Kirklin Clinic of UAB Hospital, Birmingham
- The University of Alabama at Birmingham, Birmingham
RekryterarFas 2/3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06989437A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Investigative Site US058, Birmingham
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07522073Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach
- University of Alabama at Birmingham, Birmingham
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 10 sep. 2026 · NCT05764720Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
- University of Alabama at Birmingham Cancer Center, Birmingham
- University of South Alabama Mitchell Cancer Institute, Mobile
RekryterarObservationsstudie
Ålder 50 till 75 · Alla kön · Uppdaterad 4 sep. 2026 · NCT04239573Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- University of Alabama at Birmingham, Birmingham
- University of South Alabama, Mobile
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 30 apr. 2026 · NCT05297734A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
- Ohio State University-Telemedicine, Birmingham
- Ohio State University-Telemedicine, Mobile
- Ohio State University Telemedicine, Montgomery
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 17 feb. 2026 · NCT06906562SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Birmingham
- Massive Bio SYNERGY-AI site, Mobile
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 28 okt. 2025 · NCT03452774American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
- University of Alabama Birmingham, Birmingham
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 25 feb. 2025 · NCT02674100Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.